Sutro Biopharma announced that it has appointed James A. Wells, PhD, and James R. Swartz, ScD, to its newly formed scientific advisory board (SAB).
Wells, a professor in pharmaceutical sciences and director of the Small Molecule Discovery Center at the University of California, San Francisco, will serve as chairman of the SAB.
Swartz is a director and founder of Sutro Biopharma, and is a professor in the departments of bioengineering and chemical engineering at Stanford University.
Release Date: Jan. 7, 2012
Source: Sutro Biopharma